ConductScience.org, home

Paper40097577

The fibroinflammatory response in cancer.

Xiao Z and 1 other. Nat Rev Cancer, 2025. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. The fibroinflammatory response in cancer. Papers, record 40097577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40097577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The fibroinflammatory response in cancer.
PubMed
Journal
Nat Rev Cancer
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
11.51, provisional
iCite
Revised in PubMed
2026-11-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xiao ZZebinhttps://orcid.org/0000-0002-3311-7403
2Puré EEllenhttps://orcid.org/0000-0003-2107-3711

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
InflammationMajor topic
FibroblastsMajor topic
Humans
Animals
Fibrosis

Source PubMed

Download CSV of topics

References302

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119931152Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell2009https://conductscience.org/library/papers/19931152PubMed
230130584Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases.Matrix Biol2019https://conductscience.org/library/papers/30130584PubMed
328486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
429443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
538039967The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer.Immunity2023https://conductscience.org/library/papers/38039967PubMed
631144616DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs.Elife2019https://conductscience.org/library/papers/31144616PubMed
719051218Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness.J Tissue Eng Regen Med2009https://conductscience.org/library/papers/19051218PubMed
834106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
938168935Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy.Nat Cancer2024https://conductscience.org/library/papers/38168935PubMed
1020627072Tumors as organs: complex tissues that interface with the entire organism.Dev Cell2010https://conductscience.org/library/papers/20627072PubMed
1134644529Spatially confined sub-tumor microenvironments in pancreatic cancer.Cell2021https://conductscience.org/library/papers/34644529PubMed
1226390428A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.Pancreas2016https://conductscience.org/library/papers/26390428PubMed
1328564607Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts.Cell Rep2017https://conductscience.org/library/papers/28564607PubMed
1435365629Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer.Nat Commun2022https://conductscience.org/library/papers/35365629PubMed
1528368410Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.Oncogene2017https://conductscience.org/library/papers/28368410PubMed
1625473038Wound repair and regeneration: mechanisms, signaling, and translation.Sci Transl Med2014https://conductscience.org/library/papers/25473038PubMed
1723728338Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.Oncogene2014https://conductscience.org/library/papers/23728338PubMed
1834336660CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.Front Oncol2021https://conductscience.org/library/papers/34336660PubMed
1931394082Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults.Gastroenterology2020https://conductscience.org/library/papers/31394082PubMed
2036270275Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.Cancer Cell2022https://conductscience.org/library/papers/36270275PubMed

See all 302 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42966878Loss of Lepr in Fibroblasts Drives Tumor Development by Promoting Macrophage Infiltration.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42966878PubMed
42902290ADAM12 in a stromal-checkpoint framework: integrating tumor microenvironment remodeling and therapy resistance in solid tumors.Cell Commun Signal2026https://conductscience.org/library/papers/42902290PubMed
42859163Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade.Exp Hematol Oncol2026https://conductscience.org/library/papers/42859163PubMed
42850294[Contrast agent strategies in elective oncological imaging].Radiologie (Heidelb)2026https://conductscience.org/library/papers/42850294PubMed
42787877Balancing immunosuppression and cancer survival in the treatment of immune checkpoint inhibitor-associated inflammatory arthritis.EULAR Rheumatol Open2026https://conductscience.org/library/papers/42787877PubMed
42784692Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.Science2026https://conductscience.org/library/papers/42784692PubMed
42768179Understanding and targeting the tumour matrisome.Nat Rev Clin Oncol2026https://conductscience.org/library/papers/42768179PubMed
42706582Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis.Exp Hematol Oncol2026https://conductscience.org/library/papers/42706582PubMed
42694678Cancer-associated fibroblasts and immune remodeling in laryngeal squamous cell carcinoma: evidence and translational perspectives.Front Immunol2026https://conductscience.org/library/papers/42694678PubMed
42693091PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.Nat Commun2026https://conductscience.org/library/papers/42693091PubMed
42688889Molecular insights of a Unani formulation in targeting fibrosis-associated diseases.Front Pharmacol2026https://conductscience.org/library/papers/42688889PubMed
42683260Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.Front Immunol2026https://conductscience.org/library/papers/42683260PubMed
42622885RaFiST: a radiomics model for non-invasive stratification of tumor fibrosis and prognostic prediction in non-small cell lung cancer.Eur Radiol2026https://conductscience.org/library/papers/42622885PubMed
42457720Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.Nat Commun2026https://conductscience.org/library/papers/42457720PubMed
42452969Reprogramming the Immunosuppressive Microenvironment in Triple-Negative Breast Cancer via FAP-Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy.Adv Mater2026https://conductscience.org/library/papers/42452969PubMed
42417161The extracellular matrix in cancer-associated fibrosis: molecular mechanisms and clinical relevance.JCI Insight2026https://conductscience.org/library/papers/42417161PubMed
42305546The trinity of T cell engagement: navigating the molecular and clinical landscape of CAR-T, TILs, and TCEs in the war against cancer.Front Immunol2026https://conductscience.org/library/papers/42305546PubMed
42292370Research progress on tumor extracellular matrix stiffness and immunosuppression.Front Immunol2026https://conductscience.org/library/papers/42292370PubMed
42278381Dihydrosanguinarine: A Review of Its Pharmacology, Structure-Activity Relationship, Toxicity, Pharmacokinetics, and Clinical Prospects.Int J Mol Sci2026https://conductscience.org/library/papers/42278381PubMed
42219498Bidirectional crosstalk between cancer-associated fibroblasts and tumor immunity: shaping the microenvironment and response to immune checkpoint therapy.Exp Hematol Oncol2026https://conductscience.org/library/papers/42219498PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40097577

GET https://conductscience.org/api/papers/v1/40097577/references?page=2